Rocket Surgery AS
ASActiveOrg 825565922Elgfaret 27, 1453 BjørnemyrBuying and selling of own real estate· NACE 6811Est. 2020 · 6 years old0 employees
Loading company…
Overview
Rocket Surgery AS is a Norwegian AS based in Bjørnemyr, operating in the Buying and selling of own real estate sector. Incorporated in 2020, the company has 0 employees and reported revenue of NOK 28.8k in its latest annual filing.
Revenue 2025
0M NOK
−64% vs 2024
EBITDA margin
−125.7 %
+10% vs 2024
Net profit 2025
-1.4M NOK
-197% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
99.0 %
Very strongAmong the 10% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
59.4×
Very strongAmong the 10% highest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
-404.2 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
EBITDA — year on year
NOK thousandsKey figures
Annual report 2025| Revenue | 0M NOK | -64% |
| EBITDA | -0M NOK | +10% |
| Net profit | -1.4M NOK | -197% |
| Total assets | 0.3M NOK | -81% |
| Equity | 0.3M NOK | -80% |
| Employees | 0 | — |
Company information
Legal name
ROCKET SURGERY AS
Org number
825565922
Legal form
Aksjeselskap
NACE code
Founded
20 August 2020 · 6 years
Share capital
NOK 30,000
Employees
0 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Investering i aksjer, rådgiving, kjøp og salg av eiendom og styreverv, samt annet som naturlig hører inn under foranstående.
(no translation available)
Address
Elgfaret 27, 1453 Bjørnemyr
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Rocket Surgery AS reported revenue of NOK 28.8k, a decrease of 64% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of NOK 1.4m, and the EBITDA margin stood at -125.7%.
At the end of 2025, equity financed 99% of the balance sheet, and current assets covered short-term debt 59.4 times.
Financials
Revenue
NOK thousandsEBITDA
NOK thousandsIncome statement
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 29 | 80 | 44 | 60 | 630 |
| Staff expenses | -0 | -9 | -0 | -4 | -4 |
| EBITDA | -36 | -40 | -3 | 14 | 464 |
| Depreciation & amort. | -0 | -3 | -8 | -8 | -4 |
| EBIT | -36 | -43 | -10 | 6 | 459 |
| Net financials | -1,350 | 1,468 | 166 | -183 | -116 |
| Profit before tax | -1,386 | 1,424 | 155 | -177 | 343 |
| Tax | -0 | 3 | -0 | 1 | 101 |
| Net profit | -1,386 | 1,422 | 155 | -178 | 242 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 343 | 1,828 | 483 | 336 | 529 |
| Equity | 339 | 1,725 | 304 | 148 | 327 |
| Long-term debt | 0 | 0 | 1 | 0 | 1 |
| Short-term debt | 3 | 103 | 178 | 187 | 202 |
| Total debt | 3 | 103 | 179 | 187 | 202 |
Financial ratios
5-year trendEBITDA margin
-125.7 %
20212025
Equity ratio
99.0 %
Very strongAmong the 10% highest rated companies in the industry
20212025
Return on equity
-408.3 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
Net profit margin
<−999 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
Asset turnover
0.08×
AverageAround the average of companies in the same industry
20212025
Debt / equity
0.01×
Very strongAmong the 10% highest rated companies in the industry
20212025
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginWeak
Among the 30% lowest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginVery weak
Among the 10% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery weak
Among the 10% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Very weak
Among the 10% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Very weak
Among the 10% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Very weak
Among the 10% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 10% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioWeak
Among the 40% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery strong
Among the 10% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery strong
Among the 20% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioAverage
Around the average of companies in the same industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityAverage
Around the average of companies in the same industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalStrong
Among the 30% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioWeak
Among the 40% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioVery strong
Among the 10% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery strong
Among the 10% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery strong
Among the 10% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityVery strong
Among the 20% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery weak
Among the 10% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 10% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageWeak
Among the 40% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtVery weak
Among the 10% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 10% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverAverage
Around the average of companies in the same industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverStrong
Among the 40% highest rated companies in the industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalAverage
Around the average of companies in the same industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery weak
Among the 10% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtVery strong
Among the 10% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Chief Executive Officer | Chief Executive Officer | 2020 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Chairman | Chairman | 2020 |
Shareholders
Active legal ownersNo shareholder data available.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Rocket Surgery AS 
Nova Rocket ASBoard network connections
Board members of Rocket Surgery AS also hold positions in 4 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Strømnes Bøe | Chief Executive Officer | 4 companies |
Frequently asked questions
What is the Org number of Rocket Surgery AS?
Rocket Surgery AS is registered with Brønnøysundsregistrene under Org 825565922.
What is the revenue of Rocket Surgery AS?
Rocket Surgery AS reported revenue of NOK 28.8k in 2025.
Who is the CEO of Rocket Surgery AS?
Magnus Strømnes Bøe is the CEO of Rocket Surgery AS.
Who is the chairman of Rocket Surgery AS?
Magnus Strømnes Bøe chairs the board of Rocket Surgery AS.
Where is Rocket Surgery AS headquartered?
Rocket Surgery AS's registered address is Elgfaret 27.